Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Some dibenzo compounds might help treat cancer with fewer side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A man developed skin issues from cancer medication, which improved with specific treatments.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.